BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 24348513)

  • 1. Epigenetic alteration and microRNA dysregulation in cancer.
    Suzuki H; Maruyama R; Yamamoto E; Kai M
    Front Genet; 2013 Dec; 4():258. PubMed ID: 24348513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation and microRNA dysregulation in cancer.
    Suzuki H; Maruyama R; Yamamoto E; Kai M
    Mol Oncol; 2012 Dec; 6(6):567-78. PubMed ID: 22902148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of epigenetics and microRNA in hepatocellular carcinoma.
    Saito Y; Hibino S; Saito H
    Hepatol Res; 2014 Jan; 44(1):31-42. PubMed ID: 23617364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.
    Suzuki H; Maruyama R; Yamamoto E; Niinuma T; Kai M
    Adv Exp Med Biol; 2016; 927():109-35. PubMed ID: 27376733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer.
    Humphries B; Wang Z; Yang C
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review.
    Saito Y; Saito H; Liang G; Friedman JM
    Clin Rev Allergy Immunol; 2014 Oct; 47(2):128-35. PubMed ID: 24362548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer.
    Maruyama R; Suzuki H; Yamamoto E; Imai K; Shinomura Y
    Tumour Biol; 2012 Apr; 33(2):277-85. PubMed ID: 22219034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms.
    Shoaib S; Ansari MA; Ghazwani M; Hani U; Jamous YF; Alali Z; Wahab S; Ahmad W; Weir SA; Alomary MN; Yusuf N; Islam N
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of microRNAs in cancer: an integrated review of literature.
    Kunej T; Godnic I; Ferdin J; Horvat S; Dovc P; Calin GA
    Mutat Res; 2011 Dec; 717(1-2):77-84. PubMed ID: 21420983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalent histone modifications in stem cells poise miRNA loci for CpG island hypermethylation in human cancer.
    Iliou MS; Lujambio A; Portela A; Brüstle O; Koch P; Andersson-Vincent PH; Sundström E; Hovatta O; Esteller M
    Epigenetics; 2011 Nov; 6(11):1344-53. PubMed ID: 22048248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets.
    Arif KMT; Elliott EK; Haupt LM; Griffiths LR
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Silencing by DNA Methylation in Human Cancer: a Literature Analysis.
    Strmsek Z; Kunej T
    Noncoding RNA; 2015 Apr; 1(1):44-52. PubMed ID: 29861414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
    Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
    Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
    Suzuki H; Takatsuka S; Akashi H; Yamamoto E; Nojima M; Maruyama R; Kai M; Yamano HO; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
    Cancer Res; 2011 Sep; 71(17):5646-58. PubMed ID: 21734013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide epigenetic regulation of miRNAs in cancer.
    Baer C; Claus R; Plass C
    Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer.
    Lopez-Serra P; Esteller M
    Oncogene; 2012 Mar; 31(13):1609-22. PubMed ID: 21860412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG island hypermethylation of tumor suppressor microRNAs in human cancer.
    Lujambio A; Esteller M
    Cell Cycle; 2007 Jun; 6(12):1455-9. PubMed ID: 17581274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.